Posts by GVN
Eradicating Polio Will Require Changing the Current Public Health Strategy
Leadership of the Global Virus Network Say Policy Decisions Should Reflect the Science Baltimore, MD, March 6, 2023— The recent public health emergency declarations in New York and London due to polio infections and detection of the virus in these cities’ wastewater strongly indicate that polio is no longer close to being eradicated.Now, four members…Read More
Why Worry About Avian Flu?
The Covid pandemic is the latest concern regarding potential zoonotic spillover of a dangerous virus. What will actually be the next virus? In the game of spillover roulette, some have put their bets on yet another coronavirus. Lately, however, the smart money seems to be betting on avian flu, or more specifically, H5N1 avian flu.…Read More
Global Virus Network (GVN) Adds Brazil’s Laboratory for Clinical Research in Neuroinfections at Fiocruz
Baltimore, Maryland, USA, March 1, 2023: The Global Virus Network (GVN), representing 71 Centers of Excellence and 9 Affiliates in 40 countries comprising foremost experts in every class of virus causing disease in humans, and the Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro, Brazil announced the addition of the Laboratory for Clinical Research in…Read More
Global Virus Network (GVN) Leaders Publish STAT Op-Ed with a U.S. Government Call to Action and Road Map for the Future of COVID-19
BALTIMORE, MD, January 31, 2023: STAT today published “How the Biden Administration’s COVID preparedness policies could narrow America’s political divide” co-authored by leadership of the Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 37 countries, and comprising foremost experts in every class of virus causing disease in humans and some…Read More
Ebola in Uganda
A moderate sized Ebola outbreak (142 confirmed cases) in Uganda has recently been in the news. Fifty-five people died; the others recovered. It has now largely been controlled, but there are some issues associated with the outbreak that are worth considering. These relate to conventional control by contact tracing and isolation (which was how it…Read More
Surge of SARS-CoV-2 Variants in China and USA Further Emphasizes Need for Surveillance, Preparedness, and International Collaborations
BALTIMORE, MD, January 9, 2023: Christian Bréchot, MD, PhD, President of the Global Virus Network (GVN), Associate Vice President for International Partnerships and Innovation at the University of South Florida and Professor of the Division of Infectious Disease, Department of Internal Medicine at USF Health Morsani College of Medicine, the GVN Southeast U.S. Regional Headquarters…Read More
Flu Vaccines: What Does the Future Hold?
Omicron spinoffs, respiratory syncytial virus (RSV), and influenza (flu) viruses have formed a sort of unholy trinity of respiratory infections. Covid vaccines were initially highly effective against infection, hospitalization, and death, but with the multiplication of new variants, only strong protection against hospitalization and death remains. In a previous Perspective (https://gvn.org/respiratory-syncytial-virus-newly-resurgent/), we noted that the…Read More
GVN Statement on SARS-CoV-2 Variant BF7
SARS-CoV-2 variants continue to appear worldwide. There is some concern about the variant BF7, shorthand for BA.22.214.171.124, which reportedly is spreading in China. BA.126.96.36.199 is part of the Omicron lineage of SARS-CoV-2 and had been indicated as a potential variant of concern. Recent data from the US CDC and other agencies in other countries, however, show…Read More
Global Virus Network (GVN) Announces 2022 Elected Members Of Rising Star Mentorship Program
The eleven awardees will receive training and mentorship to help support and propel their rising careers in virology BALTIMORE, MD, December 6, 2022: The Global Virus Network (GVN), a coalition comprised of human and animal virologists from 68 Centers of Excellence and 11 Affiliates in 39 countries, today announced eleven members of the 2022 GVN…Read More
Lassa fever vaccine development: Where are we?
Lassa fever vaccine development: Where are we? Joseph Anejo-Okopi, PhD1,2. 1Department of Microbiology, Faculty of Science, Federal University of Health Sciences Otukpo, Nigeria. 2AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria Email Address: [email protected], [email protected], December 5, 2022 Introduction Lassa virus (LASV) causes acute viral hemorrhagic fever (VHF) called Lassa fever (LF)…Read More